Skip to main content
Fig. 6 | BMC Medical Genomics

Fig. 6

From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer

Fig. 6

The functional enrichment analysis of SMARCAs in pancreatic cancer patients (Metascape). A Biological processes (BP). B Cellular components (CC). C Molecular functions (MF). D Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) Analysis. A P value cut-off < 0.01, a minimum overlap of 3, and a minimum enrichment factor of 1.5 were considered as statistically significant. All enriched terms colored by P value

Back to article page